Secondarily Infected Traumatic Lesions

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2018-07-23
Clinical Trial Update: The Pharmacokinetics of 2% TD1414 Cream in Adults With Secondarily Infected Traumatic Lesions (SITL) or Impetigo [Phase 2]
Phase 2 pharmacokinetics study of 2% TD1414 cream in adults with secondarily infected traumatic lesions and impetigo has completed with resu…